Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Bisoprolol Versus Intravenous Diltiazem in the Management of Atrial Fibrillation or Flutter With Rapid Ventricular Rate in the Emergency Department: A Randomized Controlled Trial

NCT06276127 is registered in ClinicalTrials.gov with Oman Medical Speciality Board as lead sponsor.

NCT NCT06276127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06276127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Bisoprolol Versus Intravenous Diltiazem in the Management of Atrial Fibrillation or Flutter With Rapid Ventricular Rate in the Emergency Department: A Randomized Controlled Trial
Lead sponsor
Oman Medical Speciality Board
Phase
Phase 3
Overall status
Not yet recruiting
Start date
April 30, 2025
Completion date
June 30, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation with rapid ventricular response, atrial flutter with rapid ventricular response